Dual‐[ <sup>18</sup> FMISO + <sup>18</sup> FLT] PET/CT and MRI imaging in glioblastoma
Dual-[FMISO+FLT]-PET can provide detailed characterization of tumor microenvironment and interaction of multiple hallmarks that yield radio-resistance. This can improve the accuracy of image-guided radiosurgery and radiotherapy, thereby improving clinical outcomes in patients with glioblastoma and IDH-mutant WHO grade 4 astrocytoma.
Authors
- Benjamin Liechty (ORCID: https://orcid.org/0000-0001-6485-5604)
- D.J. Kadrmas
- Jana Ivanidze (ORCID: https://orcid.org/0000-0002-6470-5400)
- Sadek A. Nehmeh (ORCID: https://orcid.org/0000-0002-3129-5003)
- Rajiv Magge (ORCID: https://orcid.org/0000-0002-2870-6895)
- Howard A. Fine (ORCID: https://orcid.org/0000-0002-6169-5702)
- Theodore H. Schwartz (ORCID: https://orcid.org/0000-0003-4464-7394)
- Stefan Guhlke
- Jazmin Schwartz (ORCID: https://orcid.org/0000-0001-9367-4538)
- Ramon Barajas (ORCID: https://orcid.org/0000-0001-5093-4168)
- Chang Cui (ORCID: https://orcid.org/0000-0002-5349-6295)
- Phelipi Nunes Schuck (ORCID: https://orcid.org/0000-0002-8864-8674)
- William Calimag
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Oregon Health & Science University (US)
- Cornell University (US)
- Multiconsult (Norway) (NO)
Publication Details
- Journal
- Medical Physics
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/mp.18124
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00